News
Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to ...
Hosted on MSN1mon
Gossamer Gear The One tent | Tested and reviewedWhen it comes to ultralight backpacking, every gram counts. That’s why I was eager to test the Gossamer Gear The One – a single-skin trekking pole tent that promises big space with minimal weight.
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that ...
Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price cut by The Goldman Sachs Group from $8.00 to $7.00 in a research report sent to investors on Thursday,Benzinga reports.They ...
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results